Diagnostic Yield of Post PRandial Esophageal High Resolution Impedance Manometry in Patients With Gastro-Esophageal Reflux Disease Symptoms Resistant to Proton Pump Inhibitor Therapy
NCT03596476 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 330
Last updated 2024-06-26
Summary
Gastro-esophageal reflux disease (GERD) is defined as the reflux of gastric content into the esophagus that causes troublesome symptoms or complications. Nine to 30% of the population suffers from GERD-suggestive symptoms (heartburn, regurgitation, chest pain, chronic couch, sore throat). In the absence of warning signs, proton pump inhibitors (PPI) are prescribed as first-line treatment. However, 20 to 60% of patients are unsatisfied because of persistent symptoms when taking PPI. Causes of persistent symptoms are: erroneous diagnosis of GERD (up to 50% of PPI non-responders), rumination syndrome, excessive weakly acid reflux on PPI due to defective esophago-gastric junction or an excessive number of transient lower esophageal sphincter relaxations (main mechanism of GERD), poor acid secretion inhibition on PPI, and non-compliance to therapy. Complementary examinations are indicated to explain persistent GERD symptoms. Upper gastro-intestinal endoscopy is performed first to rule out an esophageal tumor and to identify erosive esophagitis, a specific sign of GERD. However, it is normal in up to 70% of symptomatic GERD patients. Direct detection of reflux episodes is then requested to confirm GERD. The gold standard for reflux detection is the ambulatory measurement of esophageal pH for 24 to 96 hours using a catheter (catheter-based pH-monitoring) or a capsule clipped into the esophagus (wireless pH-monitoring). Reflux episodes are defined as an esophageal pH \< 4. Another method of reflux detection is based on liquid and gas detection in the esophagus using pH-impedance monitoring. Recently the combination of impedance and esophageal pressure monitoring, called esophageal high resolution impedance manometry (HRIM) was introduced to simultaneously identify reflux episodes and their mechanisms. It has several advantages over esophageal pH measurement: shorter recording duration (1 or 2 hours post prandial) and identification of reflux mechanisms that might guide the choice of the best therapeutic option.
Hypothesis: The 1-hour post prandial esophageal HRIM might be useful to diagnose GERD.
Conditions
- Gastro-esophageal Reflux Disease
Interventions
- PROCEDURE
-
Upper gastrointestinal (GI) endoscopy
An upper gastrointestinal (GI) endoscopy will be performed at V1. Four esophageal biopsies will be taken in both the proximal and the distal esophagus.
- PROCEDURE
-
Wireless pH monitoring
Wireless pH monitoring will be performed at V1. The pH capsule will be clipped into the esophagus during the upper GI endoscopy. The esophageal pH will be recorded for 96 hours (ambulatory recording).
- PROCEDURE
-
Post prandial esophageal High Resolution Impedance Manometry
Post prandial esophageal HRIM will be performed at V2. The recording will be started after transnasal insertion of the HRIM probe. A standardized meal will be given to the patient (Big Mac, medium portion of French fries, orange juice). The recording will be realized for one hour after the end of the meal.
- PROCEDURE
-
pH-impedance monitoring
24-h pH-impedance monitoring on PPI will be performed at V3. A transnasal catheter will be inserted into the esophagus and the recording will be performed for 24 hours (ambulatory recording).
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-03
- Primary Completion
- 2027-05-03
- Completion
- 2027-05-03
Countries
- France
Study Locations
More Related Trials
-
Prospective Evaluation of PH-impedance Tracings According to the Wingate Consensus, and Influence on GERD Classification According to the Lyon Consensus
NCT06084572 ·Status: RECRUITING
-
Transient Lower Esophageal Sphincter Relaxations and High Resolution Manometry
NCT00931593 ·Status: UNKNOWN ·Phase: NA
-
Measurement of Gastric Secretion by MRI Under Inhibition by ProtonPump Inhibitors in Healthy Subjects & in GERD Patients
NCT01212614 ·Status: COMPLETED ·Phase: NA
-
High Resolution Manometry After Partial Fundoplication for Gastro-oesophageal Reflux
NCT05132816 ·Status: RECRUITING ·Phase: NA
-
A New System for GERD Diagnosis and Treatment
NCT03600974 ·Status: UNKNOWN
-
Diagnostic of Transient Lower Esophageal Sphincter Relaxation With Combined Impedance and High Resolution Manometry in Patients With GERD
NCT01844440 ·Status: COMPLETED ·Phase: NA
-
Validation of HRM Score for the GERD Diagnosis
NCT05851482 ·Status: COMPLETED ·Phase: NA
-
Can We Predict Who Has Gastroesophageal Reflux Disease (GERD)?
NCT01204931 ·Status: COMPLETED
-
Retrospective Observational Study on GERD Management in General Hospitals in Korea
NCT06974903 ·Status: COMPLETED
-
[Impedance Measurement for Non-Erosive Reflux Disease
NCT02997527 ·Status: WITHDRAWN ·Phase: NA
-
Usefulness of Wireless pH Monitoring in GERD Diagnosis
NCT05452603 ·Status: COMPLETED
-
Biology in Patients With Reflux Esophagitis
NCT01194323 ·Status: COMPLETED
-
The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients
NCT02149914 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic Tests in Supra-Esophageal Gastroesophageal Reflux Disease (SE-GERD)
NCT05695846 ·Status: WITHDRAWN ·Phase: NA
-
Endoscopic Treatment of Gastroesophageal Reflux Disease
NCT05678491 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD
NCT02670642 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment Response of Maintenance Dose of Proton Pump Inhibitor in Patients With Nonerosive Gatroesophageal Reflux Disease
NCT03436914 ·Status: COMPLETED ·Phase: NA
-
Post-Market Registry for the Evaluation of RefluxStop in GERD Treatment
NCT05870163 ·Status: RECRUITING
-
Screening for Barrett's Esophagus in Otolaryngology Patients
NCT00695227 ·Status: COMPLETED ·Phase: NA
-
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study
NCT00235677 ·Status: COMPLETED ·Phase: PHASE3
-
Anti-Reflux Mucosectomy in the Treatment of Refractory Gastro-esophageal Reflux
NCT05745012 ·Status: RECRUITING ·Phase: NA
-
Gastroesophageal Reflux Disease Diagnostic Trial
NCT06504134 ·Status: NOT_YET_RECRUITING
-
HRIM vs Mucosal Impedance in GERD Participants
NCT02812407 ·Status: WITHDRAWN ·Phase: NA
-
Important Correlation Between Anxiety and Reflux Symptoms in Patients With Gastroesophageal Reflux Disease
NCT06151067 ·Status: COMPLETED
-
Prospective Evaluation of Symptom Resolution in Acid Versus Non-acid Reflux Disease Following Anti-reflux Surgery
NCT01241149 ·Status: TERMINATED ·Phase: NA